We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.08B
AUM Growth
-$5.49M
Cap. Flow
-$122M
Cap. Flow %
-5.86%
Top 10 Hldgs %
17.85%
Holding
3,178
New
224
Increased
394
Reduced
834
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 13.75%
2 Financials 12.3%
3 Industrials 9.98%
4 Consumer Discretionary 9.01%
5 Healthcare 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFSW
2751
DELISTED
PFSweb, Inc.
PFSW
$13K ﹤0.01%
+1,362
New +$13.4K
IHC
2752
DELISTED
Independence Holding Company
IHC
$13K ﹤0.01%
394
-271
-41% -$9.79K
IMDZ
2753
DELISTED
Immune Design Corp.
IMDZ
$13K ﹤0.01%
2,948
+2,074
+237% +$8.26K
SLY
2754
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$13K ﹤0.01%
181
+1
+0.6% +$71
BCBP icon
2755
BCB Bancorp
BCBP
$158M
$12K ﹤0.01%
832
CHMG icon
2756
Chemung Financial Corp
CHMG
$396M
$12K ﹤0.01%
245
DGICA icon
2757
Donegal Group Class A
DGICA
$693M
$12K ﹤0.01%
916
EOLS icon
2758
Evolus
EOLS
$551M
$12K ﹤0.01%
425
EVI icon
2759
EVI Industries
EVI
$187M
$12K ﹤0.01%
308
FUNC icon
2760
First United
FUNC
$293M
$12K ﹤0.01%
+582
New +$11.9K
XRN
2761
Chiron Real Estate Inc
XRN
$465M
$12K ﹤0.01%
261
GYRE icon
2762
Gyre Therapeutics
GYRE
$704M
$12K ﹤0.01%
+132
New +$23.2K
LCTX icon
2763
Lineage Cell Therapeutics
LCTX
$283M
$12K ﹤0.01%
6,864
MBCN
2764
DELISTED
Middlefield Banc Corp
MBCN
$12K ﹤0.01%
460
MCRB icon
2765
Seres Therapeutics
MCRB
$46.6M
$12K ﹤0.01%
69
NDLS icon
2766
Noodles & Co
NDLS
$93M
$12K ﹤0.01%
121
NICE icon
2767
Nice
NICE
$5.95B
$12K ﹤0.01%
118
PDLB icon
2768
Ponce Financial Group
PDLB
$494M
$12K ﹤0.01%
+1,027
New +$11.4K
PLSE icon
2769
Pulse Biosciences
PLSE
$3.17B
$12K ﹤0.01%
800
SGC icon
2770
Superior Group of Companies
SGC
$204M
$12K ﹤0.01%
573
SYBX
2771
DELISTED
Synlogic
SYBX
$12K ﹤0.01%
+82
New +$13.2K
ULH icon
2772
Universal Logistics Holdings
ULH
$503M
$12K ﹤0.01%
475
NAGE
2773
Niagen Bioscience
NAGE
$244M
$12K ﹤0.01%
+3,310
New +$12.6K
TPHS
2774
DELISTED
Trinity Place Holdings Inc.com
TPHS
$12K ﹤0.01%
1,859
HALL
2775
DELISTED
Hallmark Financial Services, Inc.
HALL
$12K ﹤0.01%
121

Similar funds

Ameritas Investment Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Ameritas Investment Partners held 3,178 positions worth $2.08B, down 0.26% from $2.08B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $122M in Q2 2018, closing 193 positions and reducing 834 holdings. Its most notable exit was Orbital ATK, Inc., an estimated $2.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Wyndham Hotels & Resorts worth $1.75M.

  • Ameritas Investment Partners's largest Q2 2018 buy was Wyndham Hotels & Resorts: 29,700 shares worth $1.75M.
  • Ameritas Investment Partners added most to Vanguard S&P 500 ETF in Q2 2018, an estimated $5.21M increase.
  • Ameritas Investment Partners's biggest Q2 2018 reduction was iShares S&P 500 Value ETF, cutting an estimated $6.02M.
  • Ameritas Investment Partners fully exited Orbital ATK, Inc. in Q2 2018, selling an estimated $2.29M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q2 2018.
  • Ameritas Investment Partners opened 224 new positions and closed 193 in Q2 2018.
  • Ameritas Investment Partners's portfolio value fell 0.26% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.